Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents

BACKGROUND: During two pivotal clinical trials of the infliximab biosimilar CT-P13 (PLANETAS and PLANETRA), antidrug antibodies (ADAs) and neutralising antibodies (NAbs) were detected in the sera of patients treated with CT-P13 and the reference product (RP; Remicade). OBJECTIVE: The aim was to asse...

Descripción completa

Detalles Bibliográficos
Autores principales: Reinisch, Walter, Jahnsen, Jørgen, Schreiber, Stefan, Danese, Silvio, Panés, Julián, Balsa, Alejandro, Park, Won, Kim, JiSoo, Lee, Jee Un, Yoo, Dae Hyun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2017
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443869/
https://www.ncbi.nlm.nih.gov/pubmed/28497221
http://dx.doi.org/10.1007/s40259-017-0219-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443869/
https://www.ncbi.nlm.nih.gov/pubmed/28497221
http://dx.doi.org/10.1007/s40259-017-0219-4

Ejemplares similares